This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Peregrine Pharmaceuticals Inc (PPHM)

NASDAQ: Health Care

Company Cash Flow
Apr 2014 Apr 2013 Apr 2012 Apr 2011
Cash Flow From Operating Activities
Net Income (Loss) -35.36M -29.78M -42.12M -34.15M
Operating Gains/Losses 4.00K 1.70M 2.00K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 330.00K 691.00K -871.00K 366.00K
(Increase) Decrease in Inventories -1.19M -728.00K 1.67M -2.16M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 -7.00K
(Decrease) Increase In Payables -391.00K -691.00K -601.00K 608.00K
(Decrease) Increase In Other Current Liabilities 995.00K -43.00K 3.88M 251.00K
(Increase) Decrease In Other Working Capital 878.00K 3.31M -1.71M 3.82M
Other Non-Cash Items 6.21M 3.44M 2.77M 2.88M
Net Cash From Continuing Operations -28.25M -20.93M -35.88M -26.46M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -28.25M -20.93M -35.88M -26.46M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -755.00K -853.00K -1.55M -912.00K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -1.77M 102.00K 383.00K -435.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -2.52M -751.00K -1.17M -1.35M
Issuance of Debt 0.00 14.75M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 73.33M 40.15M 33.42M 33.26M
Repayment of Long-Term Debt -32.00K -15.08M -1.41M -2.06M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends -232.00K 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -975.00K 0.00 0.00
Net Cash From Financing Activities 73.06M 38.85M 32.01M 31.20M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 42.29M 17.17M -5.04M 3.39M
PPHM News

PPHM Peregrine Pharmaceuticals Inc

Analysts Ratings for PPHM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PPHM ANALYST REPORT

Brokerage Partners

PPHM Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs